Results 211 to 220 of about 39,266 (270)

Machine Learning-Driven Prediction Models for Brodalumab Therapeutic Effect and Response Speed in Plaque Psoriasis. [PDF]

Psoriasis (Auckl)
Peng L, Wang L, Chen L, Shen Z.
europepmc   +1 more source

Unveiling the Metabolic Burden: A Clinicopathological Study of Chronic Plaque Psoriasis and Its Association With Metabolic Syndrome. [PDF]

Cureus
Shah S, Parikh K, Shah ML, Kothari A.
europepmc   +1 more source

Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results from the DERMIS Phase III Trials. [PDF]

Dermatol Ther (Heidelb)
Papp KA, Del Rosso JQ, Lebwohl MG, Gooderham MJ, Hebert AA, Hong HC, Kircik LH, Pariser DM, Stein Gold L, Strober B, Seal MS, Krupa D, Chu DH, Burnett P, Berk DR, Higham RC.   +15 more
europepmc   +1 more source

Efficacy and safety of vunakizumab in moderate-to-severe plaque psoriasis patients with different body mass index: a <i>post hoc</i> analysis based on a phase III trial. [PDF]

Front Pharmacol
Wang X, Li L.
europepmc   +1 more source

Guselkumab for plaque psoriasis

, 2019
openaire   +1 more source

Bimekizumab for plaque psoriasis.

Australian prescriber
openaire   +1 more source

Guselkumab for plaque psoriasis.

Australian prescriber
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Plaque-type psoriasis inhibitors

International Immunopharmacology, 2021
Psoriasis is a common inflammatory skin disorder, which is mediated by the immune system and affects 1-4% of the world's population. Psoriasis is caused by a complex interaction between the immune system, autoantigens, psoriasis-associated genetic factors, and various environmental factors.
Saeideh Sadat Shobeiri, Motahareh Khorrami, Mojtaba Sankian   +2 more
openaire   +2 more sources

Guttate and Plaque Psoriasis

Dermatologic Clinics, 1995
Guttate and plaque psoriasis are regarded as variants of one disease but present with distinct clinical and histologic appearances. This article focuses special attention on different pathways in the development and clinical course of each, with emphasis on immunologic correlations regarding HLA system linkage and therefore genotypical expression.
E, Christophers, P, Kiene
openaire   +2 more sources